Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinosarcoma × cediranib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Gliosarcoma 6 Glioblastoma 6 Brain Neoplasms 4 Sarcoma, Alveolar Soft Part 3 Sarcoma 3 Neoplasms 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Recurrence 1 Rectal Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Hairy Cell 1 Intraocular Lymphoma 1 Immunoblastic Lymphadenopathy 1

Interventions

Specimen Handling 8 Paclitaxel 6 Magnetic Resonance Spectroscopy 6 Nivolumab 5 Carboplatin 5 Biopsy 5 pembrolizumab 3 X-Rays 3 olaparib 2 ceralasertib 2 Taxes 2 trastuzumab deruxtecan 1 sargramostim 1 rucaparib 1 ribociclib 1 pelcitoclax 1 pazopanib 1 pamiparib 1 durvalumab 1 cobimetinib 1 cediranib 1 cabozantinib 1 belinostat 1 atezolizumab 1 apatinib 1 Trabectedin 1 Tissue Banks 1 TIC10 compound 1 Radiation 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown

GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡